KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED

Krishna Institute of Medical Sciences Limited

Equities

KIMS

INE967H01017

Healthcare Facilities & Services

Market Closed - NSE India S.E. Other stock markets 12:43:52 28/05/2024 BST			5-day change	1st Jan Change
1,850 ^INR	+1.62%		-5.24%	-6.53%

05-21	Krishna Institute of Medical Sciences to Invest Up to INR713 Million in Wholly Owned Arm	MT
05-17	Krishna Institute of Medical Sciences Logs Lower Consolidated Net Profit in Fiscal Q4	MT

Krishna Institute of Medical Sciences Limited Announces Ceasation of Pankaj Vaish as Independent Director

January 08, 2024 at 04:59 am

Krishna Institute of Medical Sciences Limited informed that Mr. Pankaj Vaish has completed his first term of 3 (Three) years as an Independent Director of the Company and ceases to be Independent Director effective from the end of the day 7th January 2024 @11.59.59 pm.

Latest news about Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences to Invest Up to INR713 Million in Wholly Owned Arm	05-21	MT
Krishna Institute of Medical Sciences Logs Lower Consolidated Net Profit in Fiscal Q4	05-17	MT
Transcript : Krishna Institute of Medical Sciences Limited, Q4 2024 Earnings Call, May 17, 2024	05-17
Krishna Institute of Medical Sciences Buys Land For New Hospital in Thane, India	03-15	MT
Krishna Institute of Medical Sciences Plans INR5 Billion Investment to Build Hospital in Thane, India	03-05	MT
Krishna Institute of Medical Sciences Limited Enters into Definitive Agreements for Taking Land on A 99-Year Lease and Purchase of Building for the Setting Up of New Hospital At Thane	03-04	CI
Krishna Institute of Medical Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-03	CI
Krishna Institute of Medical Sciences Limited Announces Cessation of Rajeswara Rao Gandu as Independent Director	01-25	CI
Krishna Institute of Medical Sciences Limited acquired 5.04% stake in KIMS-SUNSHINE Hospitals for INR 740 million.	01-09	CI
Krishna Institute of Medical Sciences Limited Announces Ceasation of Pankaj Vaish as Independent Director	01-08	CI
BCAL Diagnostics Joins Forces to Conduct Breast Cancer Blood Test Study in India	11-29	MT
Krishna Institute of Medical Sciences Limited Appoints Adwik Bollineni as Additional Director	11-28	CI
Krishna Institute Of Medical Sciences Reports Decline in Fiscal Q2 Consolidated Net Profit	11-08	MT
Krishna Institute of Medical Sciences Limited Announces Resignation of Shantanu Rastogi as Non-Executive & Non-Independent Director	11-07	CI
Krishna Institute of Medical Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-07	CI
Krishna Institute of Medical Sciences Acquires Additional Stake in Subsidiary	31/10/23	MT
Krishna Institute of Medical Sciences Limited acquired an additional 6.86% in Spanv Medisearch Lifesciences Private Limited for INR 270 million	30/10/23	CI
Krishna Institute of Medical Sciences Acquires Additional 5.7% Stake in SPANV Medisearch	27/10/23	MT
Krishna Institute of Medical Sciences Limited acquired an additional 5.72% stake in Spanv Medisearch Lifesciences Private Limited for approximately INR 222 million.	25/10/23	CI
Krishna Institute's Arm Acquires 12% Stake in Kondapur Healthcare	25/10/23	MT
Krishna Institute Arm Acquires Additional 13% Stake in Kondapur Healthcare	12/09/23	MT
Krishna Institute of Medical Sciences Arm Acquires 8% Stake in Kondapur Healthcare	18/08/23	MT
Krishna Institute of Medical Sciences Unit Picks Up 8.06% Stake in Kondapur Healthcare	17/08/23	MT
Krishna Institute of Medical Sciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	07/08/23	CI
Krishna Institute of Medical Sciences Limited acquired an additional 2.49% stake in Sarvejana Healthcare Private Limited for INR 350 million.	01/08/23	CI

Chart Krishna Institute of Medical Sciences Limited

Duration

Period

Chart Krishna Institute of Medical Sciences Limited

More charts

Company Profile

Krishna Institute of Medical Sciences Ltd is an India-based company that is principally engaged in the business of rendering medical and healthcare services. The Companyâs departments include accident, Alzheimer center, andrology and infertility center, pediatric obesity, pediatric oncology, pediatric oncology and hematology center, pediatric orthopedics and rheumatology, pediatric renal center, pediatric surgical center, female urology center, fertility center, gastrointestinal oncology, general surgery, heart wellness center and hepatobiliary surgery center. Its technologies include 4-Arm HD da Vinci Robotic Surgical System, O-Arm Scanner, Novalis Tx Linear Accelerator, 3 Tesla MRI, EBUS, Spy Glass, Mako Robotic for Knee Replacement, and Impella. The Companyâs institutes include the institute of Cardiac Sciences, Institute of Dental Science, Institute of Gastroenterology & Hepatology, Institute of Heart & Lung Transplantation, and Institute of Neuro Sciences.

Sector

Healthcare Facilities & Services

Calendar

05/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Krishna Institute of Medical Sciences Limited

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1,850 INR

Average target price

2,255 INR

Spread / Average Target

+21.90%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED	-6.53%	1.75B
HCA HEALTHCARE, INC.	+17.73%	83.47B
CVS HEALTH CORPORATION	-32.08%	69.72B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-3.24%	26.37B
FRESENIUS SE & CO. KGAA	+4.13%	17.86B
LABCORP HOLDINGS INC.	-13.68%	16.83B
QUEST DIAGNOSTICS INCORPORATED	+0.75%	15.7B
NATERA, INC.	+74.92%	13.45B
TENET HEALTHCARE CORPORATION	+73.16%	12.81B
REDE D'OR SÃO LUIZ S.A.	-2.02%	12.44B

Other Healthcare Facilities & Services